⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OCGN News
Ocugen, Inc. Common Stock
Ocugen to Provide Business Update and Third Quarter 2026 Financial Results on November 4
globenewswire.com
OCGN
Form 8-K
sec.gov
OCGN
Form 8-K
sec.gov
OCGN
Ocugen and Roots Pharmaceutical Complete License Agreement for OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa
globenewswire.com
OCGN
Did Ocugen, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com
OCGN
Hemostemix Announces Full LARTA Approval, Manufacturing Progress and Financing Update Ready to Announce with Confidence?
newsfilecorp.com
OCGN
Ocugen Appoints Industry Executive Jolanda Crombach General Manager of European Affiliate
globenewswire.com
OCGN
Form 8-K
sec.gov
OCGN
Ocugen to Participate in Upcoming Scientific Conferences
globenewswire.com
OCGN
Ocugen to Participate in Upcoming October Investor and Industry Conferences
globenewswire.com
OCGN